gastric cancer
ASLAN Commences Taiwan Trials For Gastric Cancer Drug
ASLAN has begun treating its first gastric cancer patients in Taiwan, where 4,000 people are affected by the disease annually.
“Cryptic Promoters” Drive Stomach Cancer
Using a new technique called Nano-ChIPseq, scientists have found that stomach cancer is driven by mutations in regions of the genome known as cryptic promoters.
Immune Protein Could Fight Gastric Cancer
Normally only produced by immune cells, IL23A has now been shown to be important in the response to H. pylori infection which could lead to gastric cancer.
Potential Marker For Gastric Cancer Stem Cells
Researchers have identified a marker that could help distinguish gastric cancer stem cells from normal, healthy cells.
Study Shows How Bacteria Infects Stomach & Gut
Scientists have uncovered how a stomach ulcer-causing bacteria sticks to and infects the lining of the stomach and gut.
Eddingpharm Acquires Small Molecule Drug Assets From ACT Biotech
Eddingpharm has signed an asset purchase agreement with ACT Biotech to acquire worldwide rights to its three small molecule drug assets Telatinib, ACTB1003 and ACTB1010.
SIMM, Crown BioScience To Build Mouse Xenograft Model Center
Shanghai Institute of Materia Medica and Crown BioScience, Inc. have agreed to jointly build a mouse clinical trial center in China.
ASLAN Pharmaceuticals Secures US$22m In Series B Financing
ASLAN Pharmaceuticals has raised US$22 million after hosting a second round of financing with Cenova Ventures.
Chemotherapy After Surgery Improves Gastric Cancer Survival
Clinical trial results show that treatment with chemotherapy after surgery improves survival for patients with advanced gastric cancer.
